ROCHOP study: A phase III randomized study of CHOP compared to romidepsin-CHOP in untreated peripheral T-cell lymphoma.
Richard Delarue
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Pier Luigi Zinzani
No relevant relationships to disclose
Mark S. Hertzberg
No relevant relationships to disclose
Won Seog Kim
No relevant relationships to disclose
Dolores Caballero
No relevant relationships to disclose
Antonio Pezzutto
No relevant relationships to disclose
Marc Andre
No relevant relationships to disclose
Maria Gomes Da Silva
No relevant relationships to disclose
Philippe Gaulard
No relevant relationships to disclose
Bertrand Coiffier
Consultant or Advisory Role - Celgene
Honoraria - Celgene